JPL Wealth Management LLC Purchases Shares of 43,317 UnitedHealth Group Incorporated (NYSE:UNH)

JPL Wealth Management LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 43,317 shares of the healthcare conglomerate’s stock, valued at approximately $21,912,000. UnitedHealth Group accounts for 6.3% of JPL Wealth Management LLC’s investment portfolio, making the stock its biggest holding.

A number of other institutional investors also recently made changes to their positions in the company. Phillips Financial Management LLC increased its stake in shares of UnitedHealth Group by 10.9% in the 4th quarter. Phillips Financial Management LLC now owns 539 shares of the healthcare conglomerate’s stock valued at $273,000 after purchasing an additional 53 shares during the last quarter. Thompson Siegel & Walmsley LLC boosted its position in shares of UnitedHealth Group by 68.0% during the 4th quarter. Thompson Siegel & Walmsley LLC now owns 2,424 shares of the healthcare conglomerate’s stock worth $1,226,000 after purchasing an additional 981 shares in the last quarter. Impact Capital Partners LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $3,186,000. DecisionMap Wealth Management LLC bought a new stake in UnitedHealth Group in the 4th quarter worth about $395,000. Finally, Penobscot Wealth Management raised its holdings in shares of UnitedHealth Group by 2.8% in the 4th quarter. Penobscot Wealth Management now owns 1,269 shares of the healthcare conglomerate’s stock worth $642,000 after purchasing an additional 35 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 1.0 %

Shares of NYSE UNH opened at $481.18 on Thursday. The stock’s 50 day moving average price is $512.33 and its two-hundred day moving average price is $551.50. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a market capitalization of $440.14 billion, a P/E ratio of 31.04, a PEG ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the business earned $5.83 earnings per share. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.75%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of recent analyst reports. KeyCorp restated an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Stephens increased their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Piper Sandler cut their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Finally, Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.